- Home
- PAVS vs ADAG Comparison
PAVS vs ADAG Comparison
Compare PAVS & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- ADAG
- Stock Information
- Founded
- PAVS 2004
- ADAG 2011
- Country
- PAVS United States
- ADAG China
- Employees
- PAVS N/A
- ADAG N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- PAVS Health Care
- ADAG Health Care
- Exchange
- PAVS Nasdaq
- ADAG Nasdaq
- Market Cap
- PAVS 49.1M
- ADAG 110.8M
- IPO Year
- PAVS 2019
- ADAG 2021
- Fundamental
- Price
- PAVS $0.76
- ADAG $2.12
- Analyst Decision
- PAVS
- ADAG Strong Buy
- Analyst Count
- PAVS 0
- ADAG 2
- Target Price
- PAVS N/A
- ADAG $7.00
- AVG Volume (30 Days)
- PAVS 149.0K
- ADAG 111.6K
- Earning Date
- PAVS 08-04-2025
- ADAG 08-12-2025
- Dividend Yield
- PAVS N/A
- ADAG N/A
- EPS Growth
- PAVS N/A
- ADAG N/A
- EPS
- PAVS N/A
- ADAG N/A
- Revenue
- PAVS $71,542.00
- ADAG $103,204.00
- Revenue This Year
- PAVS N/A
- ADAG $9,789.15
- Revenue Next Year
- PAVS N/A
- ADAG $29.92
- P/E Ratio
- PAVS N/A
- ADAG N/A
- Revenue Growth
- PAVS N/A
- ADAG N/A
- 52 Week Low
- PAVS $0.32
- ADAG $1.33
- 52 Week High
- PAVS $1.50
- ADAG $3.16
- Technical
- Relative Strength Index (RSI)
- PAVS 47.19
- ADAG 48.10
- Support Level
- PAVS $0.76
- ADAG $2.03
- Resistance Level
- PAVS $0.90
- ADAG $2.49
- Average True Range (ATR)
- PAVS 0.13
- ADAG 0.21
- MACD
- PAVS 0.00
- ADAG -0.03
- Stochastic Oscillator
- PAVS 22.73
- ADAG 7.52
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.